Oddity Tech Ltd. (ODD) stock price, financials & research

Regular session · ET · Market data may be delayed.

GoAI snapshot

Jul 10, 2026

46/ 100

GoAI Score

Hold

Valuation

83

Deep Value

Sentiment

43

Mixed

Risk

78

High Risk

Momentum

36

Weakening

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

Company profile

Company website

Operating globally, Oddity Tech Ltd. and its affiliated companies function as a consumer technology enterprise. It delivers beauty and wellness merchandise, leveraging its proprietary PowerMatch technology. The firm's strategic focus is on developing and growing digitally native brands, aiming to revolutionize the traditionally brick-and-mortar beauty and wellness sectors. Its product portfolio features items for the face, complexion, eyes, brows, lips, and general skincare, marketed under the IL MAKIAGE label. Additionally, the SpoiledChild brand specializes in hair and skin care solutions. Founded in 2013, this corporation maintains its headquarters in Tel Aviv-Jaffa, Israel.

Industry: Household & Personal Products
Sector: Consumer Defensive
Headquarters: IL
CEO: Oran Holtzman
Listed since: Jul 19, 2023
Employees: 658

Market position

Day range

Current $19.14

$18.86$19.53

52-week range

Current $19.14

$9.25$58.28

Open: $19.25
Previous close: $19.25
Volume: 407.34K; 0.29× average
Average volume: 1.43M; Average daily volume
Market cap: 1.09B USD
Beta: 2.24; Market reference 1
50-day average: $15.6606; +22.22% above average
200-day average: $19.0839; +0.29% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 2.49B USD
P/E (TTM): 63.8×
P/B (TTM): 3.75×
P/S (TTM): 1.61×
EV / EBITDA: 17.03×
Earnings yield: 4.84%
Free cash flow yield: 3.66%
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 70.01%
Operating margin: -1.14%
Net margin: 2.23%
Return on equity: 27.93%
Return on assets: 9.73%
Return on invested capital: 9.42%

Financial health

Debt / equity: 2.3×
Current ratio: 5.24×
Altman Z-score: 2.53
Piotroski F-score: 4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

809.84M USD+25.16%

Operating income

118.77M USD+2.74%

Net income

110.75M USD+9.12%

Financial statements: Income statement
Metric (USD)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	809.84M USD	647.04M USD	508.69M USD	324.52M USD	222.56M USD
Cost of goods sold	221.14M USD	178.72M USD	150.46M USD	106.47M USD	69.37M USD
Gross profit	588.71M USD	468.32M USD	358.23M USD	218.05M USD	153.18M USD
Selling, general, and administrative	469.94M USD	352.72M USD	283.91M USD	190.39M USD	133.67M USD
Operating expenses	469.94M USD	352.72M USD	283.91M USD	190.39M USD	133.67M USD
Interest income	16.94M USD	12.38M USD	4.28M USD	1.25M USD	—
Interest expense	—	76K USD	—	—	877K USD
Depreciation and amortization	10.69M USD	9.83M USD	8.61M USD	4.41M USD	4.01M USD
Operating income	118.77M USD	115.6M USD	74.32M USD	27.67M USD	19.51M USD
Net income	110.75M USD	101.49M USD	58.53M USD	21.73M USD	13.92M USD

Company facts updated Oct 8, 2026.

Earnings

EPS beat rate: 82%; 9 beats, 2 misses, 0 met estimates
Average EPS surprise: -7.11%; 11 comparable reports
Latest EPS result: 0.2; Estimate 0.12 · Beat by 63.53%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate

Latest fiscal-year EPS: 1.8; FY2025 · +8.43% year over year
Latest fiscal-year revenue: 809.84M USD; FY2025 · +25.16% year over year
Next fiscal-year EPS consensus: 0.464; FY2026 · 5 analysts
Next fiscal-year revenue consensus: 656.26M USD; FY2026 · 7 analysts

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$12.46

34.90% downside

Past 12 months12-month forecastHigh $16.50Average $12.46Low $8.00

Rating distribution

12 ratings

Strong buy00%

Buy325%

Hold758%

Sell217%

Strong sell00%

Recent analyst actions

12 institutions

ODD news

globenewswire.comSep 28, 2026

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition

NANJING, China, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that opamtistomig (LBL-024), the Company's proprietary…

Read source

gurufocus.comSep 23, 2026

ODDITY Tech Ltd (ODD) Shares Fall 5.1% -- What GF Score of 71 Tells Investors

On September 23, 2026, ODDITY Tech Ltd (ODD) shares fell 5.1% to $17.83, reflecting a significant drop in price performance over the last year, with a 52-week r

Read source

zacks.comSep 15, 2026

Earnings Estimates Moving Higher for Oddity Tech (ODD): Time to Buy?

Oddity Tech (ODD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Read source

seekingalpha.comSep 10, 2026

Oddity Tech: Turnaround Potential And Discounted Debt Value Lever

ODD's turnaround could benefit from improving acquisition costs, even if profitability takes longer to recover than revenue. SpoiledChild is a nice, growing revenue base. And METHODIQ and Labs offer longer-term…

Read source

fool.comSep 9, 2026

Why Oddity Tech's Stock Skyrocketed 26.5% Today

Oddity Tech's second-quarter sales fell 25% to $181 million, just ahead of Wall Street's target. Earnings fell from $0.92 per share to $0.20, topping analyst estimates by a penny.

Read source